6974 related articles for article (PubMed ID: 20664806)
1. Integrin A6 Cleavage in Mouse Skin Tumors.
Demetriou MC; Kwei KA; Powell MB; Nagle RB; Bowden GT; Cress AE
Open Cancer J; 2008 Jan; 2():1-4. PubMed ID: 20664806
[TBL] [Abstract][Full Text] [Related]
2. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.
Demetriou MC; Pennington ME; Nagle RB; Cress AE
Exp Cell Res; 2004 Apr; 294(2):550-8. PubMed ID: 15023541
[TBL] [Abstract][Full Text] [Related]
3. Integrin alpha6 cleavage: a novel modification to modulate cell migration.
Pawar SC; Demetriou MC; Nagle RB; Bowden GT; Cress AE
Exp Cell Res; 2007 Apr; 313(6):1080-9. PubMed ID: 17303120
[TBL] [Abstract][Full Text] [Related]
4. Spatially and temporally regulated alpha6 integrin cleavage during Xenopus laevis development.
Demetriou MC; Stylianou P; Andreou M; Yiannikouri O; Tsaprailis G; Cress AE; Skourides P
Biochem Biophys Res Commun; 2008 Feb; 366(3):779-85. PubMed ID: 18083114
[TBL] [Abstract][Full Text] [Related]
5. Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.
Ports MO; Nagle RB; Pond GD; Cress AE
Cancer Res; 2009 Jun; 69(12):5007-14. PubMed ID: 19491258
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
7. Integrin clipping: a novel adhesion switch?
Demetriou MC; Cress AE
J Cell Biochem; 2004 Jan; 91(1):26-35. PubMed ID: 14689578
[TBL] [Abstract][Full Text] [Related]
8. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
9. The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.
King TE; Pawar SC; Majuta L; Sroka IC; Wynn D; Demetriou MC; Nagle RB; Porreca F; Cress AE
PLoS One; 2008; 3(10):e3535. PubMed ID: 18958175
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract][Full Text] [Related]
11. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.
Ghosh S; Brown R; Jones JC; Ellerbroek SM; Stack MS
J Biol Chem; 2000 Aug; 275(31):23869-76. PubMed ID: 10791952
[TBL] [Abstract][Full Text] [Related]
12. Integrin laminin receptor profile of pulmonary squamous cell and adenocarcinomas.
Patriarca C; Alfano RM; Sonnenberg A; Graziani D; Cassani B; de Melker A; Colombo P; Languino LR; Fornaro M; Warren WH; Coggi G; Gould VE
Hum Pathol; 1998 Nov; 29(11):1208-15. PubMed ID: 9824097
[TBL] [Abstract][Full Text] [Related]
13. Knockout of alpha6 beta1-integrin expression reverses the transformed phenotype of hepatocarcinoma cells.
Carloni V; Romanelli RG; Mercurio AM; Pinzani M; Laffi G; Cotrozzi G; Gentilini P
Gastroenterology; 1998 Aug; 115(2):433-42. PubMed ID: 9679049
[TBL] [Abstract][Full Text] [Related]
14. Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.
Kacsinta AD; Rubenstein CS; Sroka IC; Pawar S; Gard JM; Nagle RB; Cress AE
Biochem Biophys Res Commun; 2014 Nov; 454(2):335-40. PubMed ID: 25450398
[TBL] [Abstract][Full Text] [Related]
15. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
Wilson MJ; Sinha AA
Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
17. A splice variant of alpha 6 integrin is associated with malignant conversion in mouse skin tumorigenesis.
Tennenbaum T; Belanger AJ; Glick AB; Tamura R; Quaranta V; Yuspa SH
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7041-5. PubMed ID: 7624366
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
19. Identification of integrins alpha6 and beta7 as c-Jun- and transformation-relevant genes in highly invasive fibrosarcoma cells.
Kielosto M; Nummela P; Järvinen K; Yin M; Hölttä E
Int J Cancer; 2009 Sep; 125(5):1065-73. PubMed ID: 19405119
[TBL] [Abstract][Full Text] [Related]
20. Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression.
Khan KM; Falcone DJ
J Biol Chem; 1997 Mar; 272(13):8270-5. PubMed ID: 9079647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
